Publications by authors named "Deborah Ariza"

Claim this Profile
R
Role of the iNOS isoform in the cardiovascular dysfunctions of male rats with 6-OHDA-induced Parkinsonism.
Lorena de Jager, Camila Borecki Vidigal, Blenda Hyedra de Campos, Gabriela Souza Reginato, Lorena Maria Fernandes, Deborah Ariza

Nitric Oxide· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutamate and GABA neurotransmission are increased in paraventricular nucleus of hypothalamus in rats induced to 6-OHDA parkinsonism: Involvement of nNOS.
Eric Diego Turossi Amorim, Lorena de Jager, Andressa Busetti Martins, Ananda Totti Rodrigues, Bruno Fernando Cruz Lucchetti, Deborah Ariza

Acta Physiol (Oxf)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoreflex and baroreflex alterations in Parkinsonism induced by 6-OHDA in unanesthetized rats.
Deborah Ariza, Fernanda Novi Cortegoso Lopes, Carlos Cesar Crestani, Marli Cardoso Martins-Pinge

Neurosci Lett· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of motor, depressive-like and neurochemical alterations induced by a short-term rotenone administration.
Lívia H Morais, Marcelo M S Lima, Bruno J Martynhak, Ronise Santiago, Tatiane T Takahashi, Deborah Ariza

Pharmacol Rep· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin.
Camila G Moreira, Janaína K Barbiero, Deborah Ariza, Patrícia A Dombrowski, Pamela Sabioni, Mariza Bortolanza

Neurotox Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute but not chronic administration of pioglitazone promoted behavioral and neurochemical protective effects in the MPTP model of Parkinson's disease.
Janaína K Barbiero, Ronise M Santiago, Marcelo M S Lima, Deborah Ariza, Lívia H Morais

Behav Brain Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intranigral LPS administration produces dopamine, glutathione but not behavioral impairment in comparison to MPTP and 6-OHDA neurotoxin models of Parkinson's disease.
Deborah Ariza, Marcelo M S Lima, Camila G Moreira, Patrícia A Dombrowski, Thiago V Avila

Neurochem Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis